newsfilter
← Latest News
GlobeNewswire·

Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries

Global Expansion Complete as Germany Joins Ongoing Study of Inhaled LTI-03 in Idiopathic Pulmonary FibrosisCompany on track to report initial topline data in 2H 2026 AUSTIN, Texas, July 21, 2026 (GLOBE NEWSWIRE) --